콘텐츠로 건너뛰기
Merck
모든 사진(2)

문서

D4065

Supelco

Dirithromycin

analytical standard, for drug analysis

동의어(들):

[9S(R)]-9-Deoxo-11-deoxy-9,11-[imino[2-(2-methoxy)ethylidene]oxy]erthromycin; LY-237216

로그인조직 및 계약 가격 보기
모든 사진(2)

About This Item

실험식(Hill 표기법):
C42H78N2O14
CAS Number:
62013-04-1
Molecular Weight:
835.07
MDL number:
MFCD00865041
UNSPSC 코드:
41116107
PubChem Substance ID:
329798792

Grade

analytical standard, for drug analysis

Quality Level

100

분석

≥95% (TLC)

형태

solid

분자량

apparent mol wt 835.1

기술

HPLC: suitable
gas chromatography (GC): suitable

응용 분야

forensics and toxicology
pharmaceutical (small molecule)
veterinary

형식

neat

SMILES string

CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C4N[C@@H](COCCOC)OC([C@H]4C)[C@]1(C)O

InChI

1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32+,33-,34+,35+,36-,37-,39+,40-,41+,42-/m1/s1

InChI key

WLOHNSSYAXHWNR-KZYCBHIHSA-N

유사한 제품을 찾으십니까? 방문 제품 비교 안내

일반 설명

Chemical structure: macrolide

애플리케이션

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

픽토그램

Exclamation mark
GHS07

신호어

Warning

유해 및 위험 성명서

H317

예방조치 성명서

P280

Hazard Classifications

Skin Sens. 1

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable

개인 보호 장비

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Choose from one of the most recent versions:

시험 성적서(COA)

Lot/Batch Number
MKCG0791
MKCD2497
MKBV6004V
MKBV2310V
MKBQ6449V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

W B Shelley et al.
Journal of the American Academy of Dermatology, 40(1), 69-72 (1999-01-28)
In an open uncontrolled study of 3 patients with balanitis xerotica obliterans we have observed significant improvement after long-term systemic antibiotic therapy. Two of the patients noticed softening of the skin as well as disappearance of pruritus, tenderness, and inflammatory
In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica.
S Ranque et al.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 23(12), 932-933 (2004-12-16)
G G Zhanel et al.
Drugs, 61(4), 443-498 (2001-04-28)
The first macrolide, erythromycin A, demonstrated broad-spectrum antimicrobial activity and was used primarily for respiratory and skin and soft tissue infections. Newer 14-, 15- and 16-membered ring macrolides such as clarithromycin and the azalide, azithromycin, have been developed to address
P A Moore
Journal of the American Dental Association (1939), 130(9), 1341-1343 (1999-09-24)
When treating oral infections, clinicians have used the macrolide antibiotic erythromycin as an alternative antibiotic for patients who have documented allergic reactions to penicillins. In this article, the author reports on his assessment of the pharmacology of erythromycin and the
M M Wasilewski et al.
The Journal of antimicrobial chemotherapy, 46(2), 255-262 (2000-08-10)
We investigated the comparative efficacy and safety of dirithromycin and erythromycin in the treatment of skin and soft tissue infections in this double-blind, randomized, multicentre study, in which 439 patients were randomized to treatment with dirithromycin (500 mg daily for
모든 관련된 서류 보기

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.